February 1, 2024 · Form 4 insider transaction
McCarthy Christopher bought 10,000 shares of Interpace Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
The restricted stock units vested immediately.